Valuation: Byotrol plc

Market Cap 194K 261K 226K 211K 364K 24.88M 370K 2.48M 973K 12.47M 982K 960K 41.23M P/E 2023
-2.12x
P/E 2024 -0.06x
Enterprise Value 845K 1.14M 986K 921K 1.59M 108M 1.61M 10.8M 4.24M 54.38M 4.28M 4.19M 180M EV / Sales 2023
0.84x
EV / Sales 2024 0.21x
Free-Float
24.18%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 50 30/06/2024
Director TitleAgeSince
Director/Board Member 50 12/12/2021
Chairman 75 21/04/2024
Change 5-day change 1-year change 3-year change Capi.($)
-20.00%-20.00% - - 247K
-0.80%+0.90%-5.02%-7.09% 342B
-0.83%-1.54%-8.24%+1.48% 136B
+0.29%+2.16%+10.11%+21.29% 74.14B
+0.79%-0.25%-16.74%-18.42% 51.29B
+0.26%-0.05%-11.63%-18.31% 36.83B
+3.35%+5.30%-3.15%-48.08% 30.93B
-0.88%+0.59%-19.32%-31.48% 20.59B
+1.58%+11.81%+7.31%+29.21% 20.54B
+0.14%+1.80%+15.32%+9.81% 20.09B
Average -1.53%+1.67%-3.48%-6.84% 81.38B
Weighted average by Cap. +0.10%+1.27%-4.66%-4.91%

Financials

2023 2024
Net sales 4.59M 6.2M 5.36M 5.01M 8.64M 590M 8.77M 58.73M 23.05M 296M 23.27M 22.76M 977M 3.97M 5.36M 4.63M 4.33M 7.47M 510M 7.59M 50.77M 19.93M 256M 20.12M 19.68M 845M
Net income -1.69M -2.28M -1.98M -1.84M -3.18M -217M -3.23M -21.64M -8.49M -109M -8.57M -8.39M -360M -3.06M -4.13M -3.58M -3.34M -5.76M -394M -5.85M -39.19M -15.38M -197M -15.53M -15.19M -652M
Net Debt 287K 387K 335K 313K 540K 36.86M 548K 3.67M 1.44M 18.48M 1.45M 1.42M 61.08M 651K 879K 760K 710K 1.22M 83.61M 1.24M 8.33M 3.27M 41.91M 3.3M 3.23M 139M
Logo Byotrol plc
Byotrol Plc is a United Kingdom-based specialist infection prevention and control company. The Company operates globally in the animal and human healthcare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, molds, mycobacteria and algae. Its products can be used stand-alone or as ingredients within existing products, especially in personal hygiene, domestic and industrial disinfection, odor control, food production and food management. The Company sells products based on its anti-microbial technology to professional and consumer end users and retailers (product sales). In the professional sector, it serves human health, animal health and facilities management. In the consumer sector, it serves household, skin care and pet care. It serves customers in the United Kingdom; Europe, Middle East, and Africa (EMEA) and North America and Asia.
Employees
35